VG Life Sciences Inc. Share Price Other OTC
Equities
VGLS
US91822T1016
Biotechnology & Medical Research
Sales 2013 | - | Sales 2014 | - | Capitalization | 2.23M 186M |
---|---|---|---|---|---|
Net income 2013 | -7M -584M | Net income 2014 | -6M -501M | EV / Sales 2013 | - |
Net Debt 2013 | 2.49M 208M | Net Debt 2014 | 3.83M 319M | EV / Sales 2014 | - |
P/E ratio 2013 |
-0.25
x | P/E ratio 2014 |
-0.31
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Stricklandd
BRD | Director/Board Member | 48 | 01/17/01 |
Ana Gois
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Stricklandd
BRD | Director/Board Member | 48 | 01/17/01 |
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.4B | |
+45.94% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |